Herpes simplex virus and varicella-zoster virus infections are usually treated with acyclovir, whilst ganciclovir is used to treat cytomegalovirus. There is no known efficacious treatment for pneumonia caused by SARS coronavirus, MERS coronavirus, or hantavirus. Other forms of care are largely supportive like oxygen supplementation, treatment of comorbidities, and controlling other symptoms, fever and cough, with medications. Epidemiology
There are roughly 450 million cases of pneumonia every year. Of those case, viral pneumonia counts for about 200 million cases which includes about 100 million children and 100 million adults. Viral pneumonia is more prevalent in the very young, less than 5 years old, and in the very old, more than 75 years old. Developing countries have a higher rate of incidence when it comes to viral pneumonia. On average, developing countries have an incidence rate five times higher than that of developed countries. Being pregnant can also affect the chances of developing viral pneumonia. As with all infectious diseases, viral pneumonia preys on the immunocompromised as well as individuals with one or more comorbidities especially those with:

Trauma
Severe burns
Diabetes
Malnutrition
Poverty
Environmental Exposure
Group living

References


== External links ==
DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.A branded formulation is marketed in the U.S. as Pediarix by GlaxoSmithKline. == References ==